ConductScience.org, home

Paper39458571

Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.

Soto-Sánchez J and 1 other. Pharmaceutics, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases. Papers, record 39458571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458571

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.
PubMed
Journal
Pharmaceutics
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.72, provisional
iCite
Revised in PubMed
2024-10-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Soto-Sánchez JJacquelinehttps://orcid.org/0000-0002-1063-3130
2Garza-Treviño GGilberto

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References168

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129705579Melarsoprol Resistance in African Trypanosomiasis.Trends Parasitol2018https://conductscience.org/library/papers/29705579PubMed
229268964Natural compounds and extracts from Mexican medicinal plants with anti-leishmaniasis activity: An update.Asian Pac J Trop Med2017https://conductscience.org/library/papers/29268964PubMed
325768915Effect of Apigenin on Leishmania amazonensis Is Associated with Reactive Oxygen Species Production Followed by Mitochondrial Dysfunction.J Nat Prod2015https://conductscience.org/library/papers/25768915PubMed
436781499The Therapeutic Effects of Curcumin-coated Gold Nanoparticle Against Leishmania Major Causative Agent of Zoonotic Cutaneous Leishmaniasis (ZCL): An In Vitro and In Vivo Study.Curr Microbiol2023https://conductscience.org/library/papers/36781499PubMed
535998724In vivo schistosomicidal activity of (±)-licarin A-loaded poly(ε-caprolactone) nanoparticles.Exp Parasitol2022https://conductscience.org/library/papers/35998724PubMed
627875592Curcumin Generates Oxidative Stress and Induces Apoptosis in Adult Schistosoma mansoni Worms.PLoS One2016https://conductscience.org/library/papers/27875592PubMed
737033490Protective effects of Theracurmin treatment during experimental infection of the Colombian strain of Trypanosoma cruzi at the testicular site.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37033490PubMed
836985306Synthesis of Carvacrol-Loaded Invasomes Nanoparticles Improved Acaricide Efficacy, Cuticle Invasion and Inhibition of Acetylcholinestrase against Hard Ticks.Microorganisms2023https://conductscience.org/library/papers/36985306PubMed
931676458(±)-Licarin A and its semi-synthetic derivatives: In vitro and in silico evaluation of trypanocidal and schistosomicidal activities.Acta Trop2020https://conductscience.org/library/papers/31676458PubMed
1036430948Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense.Int J Mol Sci2022https://conductscience.org/library/papers/36430948PubMed
1131786952Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis.Expert Opin Drug Deliv2020https://conductscience.org/library/papers/31786952PubMed
1233002744Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.Cytokine2021https://conductscience.org/library/papers/33002744PubMed
1332848491The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study.Clin Med Insights Arthritis Musculoskelet Disord2020https://conductscience.org/library/papers/32848491PubMed
1436423002Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines.Vaccines (Basel)2022https://conductscience.org/library/papers/36423002PubMed
1531104636Lupeol induces immunity and protective efficacy in a murine model against visceral leishmaniasis.Parasitology2019https://conductscience.org/library/papers/31104636PubMed
1637091674Apigenin is a promising molecule for treatment of visceral leishmaniasis.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37091674PubMed
1735453582Potential of Triterpenic Natural Compound Betulinic Acid for Neglected Tropical Diseases New Treatments.Biomedicines2022https://conductscience.org/library/papers/35453582PubMed
1835708415Plant-derived compounds for the treatment of schistosomiasis: Improving efficacy via nano-drug delivery.Niger J Clin Pract2022https://conductscience.org/library/papers/35708415PubMed
1922264477New ionic derivatives of betulinic acid as highly potent anti-cancer agents.Bioorg Med Chem Lett2012https://conductscience.org/library/papers/22264477PubMed
2016569852Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16569852PubMed

See all 168 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42860538Antileishmanial potential of polar fractions from Amaranthus blitoides S. Watson, Caucalis platycarpos L., and Cistanche flava (C.A.Mey.) Korsh.: evidence from in vitro and in vivo studies.Trop Med Health2026https://conductscience.org/library/papers/42860538PubMed
42395961Curcumin Nanoencapsulated in Chitosan-Coated Liposomes: Therapeutic Potential against Pathogenic Escherichia coli and Leishmania spp.ACS Omega2026https://conductscience.org/library/papers/42395961PubMed
41977496Synthesis of New Asymmetrical Chalcones and Evaluation of Their Use in Combination with Curcumin Against Rhodesain of T. brucei rhodesiense.Int J Mol Sci2026https://conductscience.org/library/papers/41977496PubMed
41715893Mitigating PM2.5-induced skin injury and aging: botanical strategies targeting redox and inflammatory pathways.Redox Rep2026https://conductscience.org/library/papers/41715893PubMed
41155688A Review on Phytochemistry, Ethnopharmacology, and Antiparasitic Potential of Mangifera indica L.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155688PubMed
40840747Green synthesis of demethoxycurcumin-loaded chitosan nanoparticles for the management of potato late blight caused by Phytophthora infestans.Int J Biol Macromol2025https://conductscience.org/library/papers/40840747PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39458571

GET https://conductscience.org/api/papers/v1/39458571/references?page=2